FDA
-
-
-
-
-
-
-
Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow® Devices at One of its Children’s Hospitals
-
-
-
-
-
-
-
Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
-
-
-
-
-
-
-
Nuwellis receives FDA approval for dialysis catheter
-
-
-
-
-
-
-
Nuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy to Cincinnati Children’s
-
-
-
-
-
-
-
Nuwellis (NUWE) Reports New Case Series Demonstrated Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid Overload
-
-
-
-
-
-
-
Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device
-
-
-
-
-
-
-
Nuwellis (NUWE) Approved to Begin REVERSE-HF Clinical Study
-
326,861 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

